CDX2 and neoplasm: These observations led to the identification of three categories that reflect the heterogeneity of CDX2 expression within a tumor: Category 1, which exhibited positive and moderate CDX2 expression; Category 2, characterized by negative and moderate CDX2 expression; and Category 3, termed “mosaic”, which encompassed a combination of positive, moderate, and negative CDX2 expressions.